BWAY logo

BWAY BrainsWay Ltd.

NASDAQ Global Market · Medical - Specialties · Healthcare

$10.11
-0.14 (-1.37%)

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment …

Market Cap: $396.54Mwww.brainsway.com

Price

No data yet.

Social Signal Score

51
5d
—
30d
53
5 mentions
—
60d
49
7 mentions
—
90d
51
9 mentions
—
news: 9

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 1Sell 0Strong Sell 0
Avg price target$19.5+92.9%
Low $19Median $19.5High $20
Current Consensus

Revenue

$18.00M+525.74%
$2.15M$7.43M$12.71M$18.00M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.12
$0.11–$0.13
3 analysts
FY2026
$0.29+155% YoY
$0.24–$0.34
2 analysts
FY2027
$0.50+70% YoY
$0.33–$0.67
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Hadar Levy
Sector
Healthcare
Industry
Medical - Specialties
Employees
129
Beta
0.15
Country
IL
Piotroski score
7 / 9 (Strong)
Altman Z-score
5.83
www.brainsway.com